Reappraising newborn screening for cobalamin C disorder.
暂无分享,去创建一个
H. Takada | S. Ohga | S. Hirose | O. Sakamoto | M. Ishimura | Naoko Toda | Vlad Tocan | K. Nishiyama | K. Ohkubo | K. Yoshimura | Fusako Sasaki | Kanako Higashi | Kanako Kojima‐Ishii
[1] M. Baumgartner,et al. Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency , 2016, Journal of Inherited Metabolic Disease.
[2] M. Baumgartner,et al. Newborn screening for homocystinurias and methylation disorders: systematic review and proposed guidelines , 2015, Journal of Inherited Metabolic Disease.
[3] M. Baumgartner,et al. Clinical presentation and outcome in a series of 88 patients with the cblC defect , 2014, Journal of Inherited Metabolic Disease.
[4] C. Venditti,et al. Combined methylmalonic acidemia and homocystinuria, cblC type. II. Complications, pathophysiology, and outcomes , 2012, Journal of Inherited Metabolic Disease.
[5] D. Martinelli,et al. Cobalamin C defect: natural history, pathophysiology, and treatment , 2011, Journal of Inherited Metabolic Disease.
[6] E. Shoubridge,et al. Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type , 2006, Nature Genetics.